Skip to main content
Fig 5 | Cancer Imaging

Fig 5

From: Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Fig 5

Kaplan-Meier survival curves for overall survival according to (a) size and (b) volume change after four cycles of TKI treatment, (c) response rate, and (d) time to progression. Ī”S2, the percent change in tumor size based on uni-dimensional measurement at the second follow up; Ī”V2, the percent change in tumor volume at the second follow up; TTP, time to progression; RR, response rate. TKI, tyrosine kinase inhibitors

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us